7月7日，三生制药盘中下跌5.24%，报18.45港元/股，成交额3.78亿港元。
三生制药所在的生物科技行业中，个股普遍承压，其中荣昌生物跌6.49%，康方生物跌4.66%，信达生物跌3.59%，百济神州跌2.83%，科伦博泰生物跌2.48%。
三生制药是一家集研发、生产和销售为一体的生物制药企业，主要产品包括特比澳、益比奥、益赛普等生物药物，业务覆盖血小板减少症、慢性肾病贫血症、强直性脊柱炎等领域，同时从事CDMO业务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.